Showing results (71-80 of 255) with videos related to
Sort By:
Pageof 26
The EMBO Journal|February 10, 2006
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancerJeroen R Mesters, Cyril Barinka, Weixing Li, et al.AIDS (London, England)|February 27, 2024
Brain N -acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIVRobyn L Wiseman, Kristin L Bigos, Raha M Dastgheyb, et al.European Journal of Pharmacology|June 27, 2003
NAALADase inhibition protects motor neurons against chronic glutamate toxicityAjit G Thomas, Andrea M Corse, Carol F Coccia, et al.Advances in Pharmacology (San Diego, Calif.)|February 10, 2025
Neutral sphingomyelinase 2: A promising drug target for CNS diseaseMeixiang Huang, Matthew Stremlau, Jason Zavras, et al.Journal of Pharmaceutical and Biomedical Analysis|September 24, 2013
Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)Rana Rais, Camilo Rojas, Krystyna Wozniak, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 6, 2012
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivoRana Rais, Randall Hoover, Krystyna Wozniak, et al.Pharmaceutics|January 25, 2025
Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and DogsArina Ranjit, Chae Bin Lee, Lukáš Tenora, et al.Journal of Neurovirology|February 4, 2015
Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucineMichelle C Potter, Victoria K Baxter, Robert W Mathey, et al.Psychopharmacology|October 13, 2005
2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl miceEwa Kozela, Malgorzata Wrobel, Tomasz Kos, et al.Cellular Immunology|March 9, 2010
Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunizationChristine M Barbon, Min Yang, Gregory D Wands, et al.Pageof 26